Past Work

For more than a decade, the Sabin PDP collaborated with partners from across the globe to develop new, low-cost vaccines that have little commercial market for diseases that primarily impact the world's poorest populations, including human hookworm, schistosomiasis, onchocerciasis, SARS and Chagas disease. Baylor College of Medicine and Texas Children’s Hospital Center for Vaccine Development continue this research as of May 2017.

Research & Development

The Sabin Vaccine Institute supports innovative technologies and approaches in vaccine research and development to combat infectious and emerging threats to global health.  Sabin leverages the expertise of partners in the academic, public and private sectors, and promotes open-source research.

Vaccine Knowledge & Innovation

The immunization landscape is constantly evolving. Immunization professionals are faced with the challenge of staying up-to-date on new vaccines, changing policies and recommendations, and developments in vaccine science, while the general public is inundated with information, making it difficult to discern truth from fiction.

Sabin President Peter Hotez, M.D, Ph.D., was honored yesterday evening with B’nai B’rith International’s Distinguished Achievement Award for advancing science and humanity, his commitment to enlightened leadership, and community service.

Neglected tropical diseases (NTDs) are the most common affliction of the world’s poorest people. Thriving in communities that lack access to health services, adequate sanitation and clean water, NTDs blind, disable and disfigure, trapping families in a cycle of poverty and disease.

An estimated two billion people lack the medicines they need. The 2016 Access to Medicines Index analyzes pharmaceutical companies’ efforts to improve access to medicines, vaccines and diagnostics for low- and middle-income countries.

More than 500 leading scientific researchers, Catholic officials and policy makers from around the globe gathered at the Vatican on November 10-12, 2016, to address neglected tropical diseases (NTDs) and rare diseases. The Pontifical Council for Health Care Workers, which was established by Pope John Paul II to help coordinate the Vatican’s health care related activities, convened the conference. Sabin Vaccine Institute President Dr. Peter Hotez gave the keynote address on NTDs. At the conclusion of the conference, remarks from Pope Francis were shared with conference participants. These remarks highlighted how the effort to control and eliminate NTDs aligns with the Catholic Church’s social teachings, and called for international commitment to treating and preventing NTDs and rare diseases. The complete transcript of Pope Francis’s remarks are below.

Pope Francis, Sabin President Discuss Goals of the Catholic Church during Conference on Neglected Tropical Diseases

Vatican City – November 10, 2016 –Peter Hotez, M.D., Ph.D., president of the Sabin Vaccine Institute (Sabin) and director of the Sabin Product Development Partnership (Sabin PDP), today will help kick off the first-ever Vatican conference on neglected tropical diseases (NTDs) and rare diseases with a keynote address.

Sabin Vaccine Institute President Dr. Peter Hotez gave the keynote address on NTDs at the Pontifical Council for Health Care Workers’ XXXI International Conference, focused on NTDs and rare diseases.

Pages

Subscribe to RSS - Neglected Tropical Diseases